ATI RN · Obstetrics and Pediatrics · Pediatric Nursing Test Bank

Option A: 0.1 mL of 1:1000 IM adrenaline is the appropriate management for anaphylaxis in a 1-year-old child weighing 10 kg. The standard dose of adrenaline for anaphylaxis in children is 0.01 mg/kg (0.01 mL/kg of 1:1000 solution), which translates to 0.1 mL for this child. This dosage effectively counteracts severe allergic reactions by promoting bronchodilation and vasoconstriction.

Option B: 0.1 mL of 1:10,000 IM adrenaline provides a lower concentration of adrenaline, which is not suitable for immediate treatment of anaphylaxis. The correct concentration for intramuscular administration in an emergency is 1:1000.

Option C: 1 mL of 1:10,000 IM adrenaline is an excessive volume for a child of this weight and concentration. The correct volume for a 10 kg child should be 0.1 mL of 1:1000, not 1 mL of a diluted solution.

Option D: 0.1 mL of 1:10,000 SC adrenaline is inappropriate for anaphylaxis management. Subcutaneous administration is not recommended for acute allergic reactions; intramuscular injection is the standard practice for rapid absorption and effect.

Takeaways: Administering 0.1 mL of 1:1000 IM adrenaline is critical for managing anaphylaxis in children, ensuring prompt treatment for airway obstruction and ventilation during severe allergic reactions.

Option B: Dehydration during the 1st days of life does not contribute to the development of broncho-pulmonary dysplasia (BPD). BPD is primarily associated with factors such as lung immaturity, inflammation, and nutritional deficits rather than dehydration, which is not a recognized risk factor for this condition.

Option A: Immaturity is a significant factor in the development of BPD, as premature infants have underdeveloped lungs that are more susceptible to injury and inflammation, leading to this chronic lung disease.

Option C: Chorioamnionitis, an infection of the fetal membranes, is a known risk factor for BPD due to its association with inflammation and injury to the developing lungs of the neonate.

Option D: Malnutrition contributes to BPD as inadequate nutrition can impair lung development and repair mechanisms, exacerbating the risk of chronic lung disease in premature infants.

Takeaways: Understanding the contributory factors for broncho-pulmonary dysplasia (BPD) is essential for neonatal care, as priority for airway obstruction and ventilation before addressing nutritional needs can significantly impact outcomes in at-risk infants.

Option D: Acute stress reaction does not represent a psychosocial impact of war on children in the same way as the other options. While it is a psychological response to trauma, it is not a long-term psychosocial effect like loss of family members, separation from community, or lack of education, which have lasting implications on a child's development and social integration.

Option A: Loss of family members directly affects a child's emotional and psychological well-being, leading to grief and potential long-term mental health issues.

Option B: Separation from community disrupts social support systems, which are crucial for a child's development and can lead to feelings of isolation and abandonment.

Option C: Lack of education severely impacts a child's future opportunities and cognitive development, contributing to a cycle of poverty and instability.

Takeaways: Understanding the psychosocial impacts of war on children highlights the importance of addressing issues like loss of family members, separation from community, and lack of education, which requires comprehensive support systems and interventions to promote recovery and resilience.

Option D: Pressure-regulated volume control (PRVC) is the best mode for mechanical ventilation in this scenario as it provides consistent tidal volumes while adapting to changes in lung compliance and resistance, which is crucial for a newborn with respiratory distress. This mode allows for better oxygenation and ventilation while minimizing the risk of ventilator-induced lung injury.

Option A: Intermittent mechanical ventilation (IMV) does not provide adequate support for a newborn in respiratory distress, as it may lead to inadequate ventilation between mandatory breaths.

Option B: Synchronized intermittent mechanical ventilation (SIMV) can be beneficial but may not provide sufficient support for a 3-day-old infant with significant respiratory distress, as it allows spontaneous breaths that may not be effective.

Option C: Synchronized intermittent positive pressure ventilation (SIPPV) is less optimal than PRVC for this patient, as it does not adjust pressure based on lung mechanics, potentially leading to inadequate ventilation.

Takeaways: Effective mechanical ventilation in neonates, particularly those with respiratory distress, requires a mode that ensures adequate tidal volume and adapts to lung mechanics, emphasizing the priority for airway obstruction and ventilation before initiating treatment.

Option D: Daily inhaled corticosteroid and a long-acting inhaled β₂-agonist is the most appropriate treatment for a child with persistent moderate asthma symptoms. This combination therapy effectively manages chronic inflammation and provides long-term control of symptoms, reducing the frequency of exacerbations and improving overall lung function.

Option A: Oral theophylline is not the first-line treatment for persistent asthma in children and is less effective than inhaled corticosteroids. It has a narrow therapeutic index and potential side effects, making it less desirable.

Option B: Inhaled β₂-agonist as needed for symptoms is suitable for intermittent asthma but does not address the underlying inflammation in persistent asthma, which requires daily management.

Option C: Daily inhaled corticosteroid alone may not provide sufficient control for moderate persistent asthma, as the addition of a long-acting β₂-agonist enhances symptom control and reduces exacerbations.

Takeaways: Effective management of persistent asthma in children requires a combination of daily inhaled corticosteroids and a long-acting inhaled β₂-agonist to ensure optimal control of symptoms and minimize exacerbations, prioritizing long-term asthma management strategies for better outcomes.